Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02395653 · ClinicalTrials.gov registry record · Phase 3
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
A Phase 3 study of Pain, Postoperative, sponsored by The Medicines Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 71
- Enrollment target
- 10
- Study locations
NCT02395653 is a Phase 3 study of Pain, Postoperative that has completed, run by The Medicines Company. The registered enrollment target is 71 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (74% lower). The trial reports 10 study locations across 9 states.
The verdict
NCT02395653, a Phase 3 study of Pain, Postoperative, has completed, sponsored by The Medicines Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 71 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of this study is to evaluate the safety and clinical utility of the active, SSEC fentanyl 40 micrograms (mcg) for the management of acute, postoperative pain in pediatric participants.
Conditions Studied
Interventions
- DRUG fentanyl
Study Locations (10)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
California
- Packard Children's Hospital at Stanford - Palo Alto
Florida
- University of Miami/Jackson Memorial Hospital - Miami
Georgia
- Children's Healthcare of Atlanta - Atlanta
Maryland
- Johns Hopkins Hospital, Charlotte R. Bloomberg Children's Center - Baltimore
Missouri
- St. Louis Children's Hospital - St Louis
Texas
- Children's Medical Center of Dallas - Dallas
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2015-06-29 |
| Est. Completion | 2016-09-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02395653
The ClinicalTrials.gov registry entry for NCT02395653 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (74% lower). The listed sponsor is The Medicines Company, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which fentanyl is the first listed.
NCT02395653 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Pennsylvania, California, Florida.
Frequently Asked Questions
What is clinical trial NCT02395653 about?
NCT02395653 is a clinical study titled "Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants". The objective of this study is to evaluate the safety and clinical utility of the active, SSEC fentanyl 40 micrograms (mcg) for the management of acute, postoperative pain in pediatric participants.
What is the current status of trial NCT02395653?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 71 participants. The study started on 2015-06-29. Estimated completion is 2016-09-12.
What conditions does trial NCT02395653 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT02395653?
The interventions under investigation include: fentanyl (DRUG).
Who is sponsoring clinical trial NCT02395653?
This trial is sponsored by The Medicines Company, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02395653 being conducted?
This trial has 10 study locations across California, Florida, Georgia, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.